The Dental and Pharmaceutical Benefits Agency, TLV is a central government agency based in Sweden with the slogan "Mesta möjliga hälsa för skattepengarna". Founded in 2002, the agency's primary responsibility is to assess and determine which pharmaceutical products or dental care procedures should receive subsidies from the state. They play a crucial role in deciding which medicines, medical devices, and dental care treatments will be subsidized by society, as well as ensuring the quality service and accessibility of pharmacies. An important aspect of their operation involves evaluating medicines included in the high-cost threshold to ascertain whether their reimbursement should be continued or restricted. The agency also focuses on creating favorable conditions for quality service and accessibility in the pharmacy market, in part through the generic substitution system and monitoring of pharmacy market margins. Another key function is to determine the pricing for new dosage forms, strengths, and packaging, and assessing whether they should be included in the high-cost threshold. Notably, they also have the authority to decide the fees for medicines and medical devices within the high-cost threshold, as well as the margins pharmacies should apply when selling these products. The unique position of The Dental and Pharmaceutical Benefits Agency, TLV within the Swedish healthcare landscape as a government body overseeing subsidies and market conditions makes it an essential entity in the health care and pharmaceutical industry. As of the latest available information, there is no public record of their last investment or participating investors.
There is no investment information
No recent news or press coverage available for The Dental and Pharmaceutical Benefits Agency, TLV.
No funding or investment information available for The Dental and Pharmaceutical Benefits Agency, TLV at this time.